Contact Us
Contact our partnering team to discuss your project and learn more about how we can work together.
Search
TwistPak Mixing platform for swine vaccines
TwistPak® allows for fresh mixing of Ingelvac CircoFLEX® and Ingelvac MycoFLEX® on farm in less than 5 seconds
Boehringer partners with NCD Alliance
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
Tackling NCDs through innovation AND collaboration
Non-communicable diseases are a significant medical, humanitarian and socio-economic issue. Rapid innovation and holistic approaches help us tackle them
India: Many positive developments for the population
A conversation with interim country manager Sandip Agrawal about a young and growing country
Our-position
Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
Rabies prevention local action partnering organizations
Global rabies prevention needs local action. Together with partnering organizations, we’re using pilot projects to find the right approach.
Worldwide_Partnering_Contacts.pdf
Worldwide_Partnering_Contacts_May2021.pdf
Worldwide Partnering Contacts
Worldwide Contacts June 2023
Prevalence of AF worldwide.pdf
Outside the lab…inside the family
We are a manufacturing and a research company too. Outside of the lab, we have engineers, legal teams, logistics managers, QA/QC teams and more.
Poultry
Poultry
Women in the workplace: Inspiring inclusion
On International Women’s Day, we address the critical role of women in our society and ensure their voice is heard at all levels of our organization.
Enabling-Today's-Science-Infographic.pdf
enabling_todays-science_infographic.pdf
enabling_todays-science_infographic
London Partnering Day Flyer -Update V5 2018 04 18.pdf
London Partnering Day Flyer -Update V5 2018 04 18.pdf
London Partnering Day Flyer -Update V5 2018 04 18.pdf
Partnering Day France Flyer Save the date 2018 08 02.pdf
Drug Discovery at Boehringer Ingelheim
Find out more about the drug discovery process at Boehringer Ingelheim
equine asthma
Fighting Equine Asthma is a crucial step to improving the well-being of many horses worldwide. The right treatment can make a world of difference.
BIVF funding more than doubled to 250 M€
Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million